TherapeuticsMD, Inc. ( TXMD) - Key Metrics
TXMD Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $75.08 | $13.39 | $66.53 | $66.53 |
| 2026Q1 | $0.06 | $0.01 | $0.08 | $0.08 |
| 2025Q4 | $0.08 | -$0.05 | $0.03 | $0.03 |
| 2025Q3 | $0.07 | $0.01 | $0.09 | $0.09 |
| 2025Q2 | $0.08 | $0.05 | $0.03 | $0.03 |
TXMD Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | 38.91 |
| 2026Q1 | 0% | 61.59 |
| 2025Q4 | 0% | -7.62 |
| 2025Q3 | 0% | 20.61 |
| 2025Q2 | 0% | 5.80 |
TXMD Free Cash Flow Yield and Dividend Yield
| Date | Free Cash Flow Yield | Dividend Yield |
|---|---|---|
| 2026Q2 | 3010.34% | 0% |
| 2026Q1 | 4.00% | 0% |
| 2025Q4 | 1.95% | 0% |
| 2025Q3 | 8.37% | 0% |
| 2025Q2 | 2.41% | 0% |
TXMD
Price: $2.16
52 week price:
Earnings Per Share: -0.03 USD
Exchange: NMS
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Country: United States
Volume: 688
Ebitda: -21.6 millionMarket Capitalization: 25.6 million